Last reviewed · How we verify

NCT03537001: UPETEH

Use of Penthrox in Extra-hospital Traumatology

Completed Last updated 24 April 2019
What this trial tests

trial testing Penthrox in Pain, Acute in 20 participants. Completed in 30 August 2018.

Timeline
29 August 2017
Primary endpoint
30 August 2018
30 August 2018

Quick facts

Lead sponsorUniversity Hospital, Tours
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date29 August 2017
Primary completion30 August 2018
Estimated completion30 August 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

18 and older, any sex, with Pain, Acute or Trauma Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In pre-hospital settings, the administration of analgesics is often delayed because of difficult patient access (incarceration), difficulty finding a venous pathway or patient refusal. An optimization of the management of pain in urgency is therefore still necessary. A side from nitrousoxide of which usage remains restrictive, methoxyflurane (Penthrox®) is the only volatile analgesic currently available for pre-hospital use. The purpose of this study is to answer the question: Does the use of the inhaled route with Penthrox add value to the treatment of acute traumatic pain in the pre-hospital stage?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Acute

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing